Parenteral Drugs (India) Ltd - Stock Price

  • NSE : PDPL
  • BSE : 524689
  • ISIN CODE : INE904D01019
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Parenteral Drugs (India) Ltd is not traded on BSE/NSE
NSE
3.60
0 %0
BSE
3.70
-2.12 %-0.08

Ratios

Parameter MAR 19  MAR 18  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)-49.61-37.50-32.28
   CEPS(Rs)-26.42-29.3710.03
   DPS(Rs)0.000.000.00
   Book NAV/Share(Rs)-174.06-134.09-29.81
   Tax Rate(%)18.467.87134.45
Margin Ratios
   Core EBITDA Margin(%)-55.60-0.52-10611.36
   EBIT Margin(%)-266.47-10.53-2430.21
   Pre Tax Margin(%)-566.37-53.65-955.72
   PAT Margin (%)-461.81-49.42-834.39
   Cash Profit Margin (%)-246.00-38.71-535.53
Performance Ratios
   ROA(%)-23.45-13.17-78.07
   ROE(%)0.000.000.00
   ROCE(%)-35.07-5.55-531.90
   Asset Turnover(x)0.050.27-80.94
   Sales/Fixed Asset(x)0.040.25-84.78
   Working Capital/Sales(x)-0.04-0.4691.38
Efficiency Ratios
   Fixed Capital/Sales(x)26.574.04557.06
   Receivable days0.0053.24-100.00
   Inventory Days176.5658.14203.69
   Payable days100.1180.0025.13
Valuation Parameters
   PER(x)0.000.000.00
   PCE(x)-0.33-0.5439.01
   Price/Book(x)-0.05-0.1257.73
   Yield(%)0.000.000.00
   EV/Net Sales(x)20.743.62472.45
   EV/Core EBITDA(x)-40.931939.06-102.11
   EV/EBIT(x)-7.78-34.0577.15
   EV/CE(x)1.530.9855.42
   M Cap / Sales0.820.21283.83
Growth Ratio
   Net Sales Growth(%)-85.70-2.54-3271.60
   Core EBITDA Growth(%)-3977.54102.52-3979.91
   EBIT Growth(%)-258.2142.75-704.04
   PAT Growth(%)-32.285.11-731.92
   EPS Growth(%)-32.285.11-731.91
Financial Stability Ratios
   Total Debt/Equity(x)-1.23-1.9235.91
   Current Ratio(x)0.080.17-54.11
   Quick Ratio(x)0.070.12-40.63
   Interest Cover(x)-0.89-0.24-263.76
   Total Debt/Mcap(x)24.3816.0851.61

Latest News

close